Stock Information
Share Data
Stock Performance
Analyst Coverage
Advisor & Investor Contacts

Reports & Presentations

Interim & Annual Reports
Presentations
Corporate Governance
Company Information
Leadership
Board of Directors
General Meetings

Media

SEC Filings
News

Stock Information

Share Data

Stock Performance

Analyst Coverage

Advisors & Investor Contacts

Share Data

Number of ordinary shares: 2,238,225,722
Countries of listing: US

ADR Information

Ticker: BDRX
Structure: Level III ADR
Exchange: NASDAQ
Ratio: 1 ADR : 400 Ordinary Shares
DR ISIN: US59564R7089
CUSIP: 59564R708

The percentage of 0.1p Ordinary shares not being held in public hands is less than 0.01%

Shares held in treasury: Nil.

Information correct as of 9 May 2024

Stock Performance

Analyst Coverage

Biodexa Pharmaceuticals is covered by the following research analysts:

Analyst: Jyoti Prakash
Edison Investment Research Limited
London
WC1V 7EE
+44 (0) 20 3077 5700

Please note that any opinions, estimates or forecasts made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Biodexa Pharmaceuticals or its management. Requests for copies of analyst reports should be directed at the respective analyst and institution.

Advisors & Investor Contacts

Investor Relations (US)

Edison Group

1185 Avenue of the Americas
New York
NY 10036
USA
+1 646 653 7026

Solicitors

Brown Rudnick LLP

8 Clifford Street
London
W1S 2LQ
United Kingdom

Reporting Accountants and Auditors

Mazars LLP

30 Old Bailey
London
EC4M 7AU

Registrars

Neville Registrars Limited

Neville House
Steelpark Road
Halesowen
B62 8HD
United Kingdom
+44 (0)121 585 1131
info@nevilleregistrars.co.uk